(MedPage Today) — Two members of Congress launched an investigation into FDA Commissioner Marty Makary, MD, MPH, and his use of “priority vouchers” for expedited drug approvals, suggesting that the voucher program “could undermine public confidence…
Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/118690
Author :
Publish date : 2025-11-24 22:23:00
Copyright for syndicated content belongs to the linked Source.
